Biotech Aizen Therapeutics has spun out of the lab of David Van Valen at the California Institute of Technology with $13 million in seed funding. Aizen is using generative artificial intelligence ...

SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- Aizen Therapeutics, an AI-driven biotechnology company, today emerged from stealth with early-stage programs powered by its novel drug discovery platform ...